학술논문
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial
Document Type
Article
Author
Granholm, A.; Munch, M.W.; Kjær, M.-B.N.; Vesterlund, G.K.; Meyhoff, T.S.; Møller, M.H.; Perner, A.; Rasmussen, B.S.; Brøchner, A.C.; Myatra, S.N.; Divatia, J.V.; Vijayaraghavan, B.K.T.; Padmanaban, A.; Bassi, A.; John, O.; Jha, V.; Cronhjort, M.; Wahlin, R.R.; Jakob, S.M.; Cioccari, L.; Helleberg, M.; Benfield, T.; Venkatesh, B.; Hammond, N.E.; Micallef, S.; Kristiansen, K.T.; Ulrik, C.S.; Jørgensen, V.L.; Smitt, M.; Bestle, M.H.; Andreasen, A.S.; Poulsen, L.M.; Strøm, T.; Møller, A.; Khan, M.S.; Saseedharan, S.; Borawake, K.; Kapadia, F.; Dixit, S.; Chawla, R.; Shukla, U.; Amin, P.; Chew, M.S.; Wamberg, C.A.; Gluud, C.; Lange, T.
Source
In: Intensive Care Medicine . (Intensive Care Medicine, January 2022, 48(1):45-55)
Subject
Language
English
ISSN
14321238
03424642
03424642